AbelZeta Pharma Inc.

As Chinese biotech companies have faced a cash crunch at home, it has become necessary for them to look abroad for partnering opportunities to advance their assets through the clinic. This trend has l

There’s a new CAR-T kid on the block. A young Indian cell and gene therapy company, Immunoadoptive Cell Therapy (ImmunoACT), has delivered the country’s first such cell therapy for the treatment of re

Johnson & Johnson chairman and CEO Joaquin Duato kept the audience enthralled at a recent conclave as he peppered his responses around important issues ranging from diversity, equity and inclusion (D

Months after another next-generation cell therapy deal fell apart, Johnson & Johnson Janssen Biotech, Inc. is back in the ring with another one, this time with Cellular Biomedicine Group, Inc. (CB